Flight compression socks cut silent clots. No dangerous clot appeared in the trials

Compression stockings do work on long flights — a Cochrane review of 11 randomised trials found they dramatically reduce the risk of a symptomless deep-vein clot [s1]. But the same review carries a caveat that reframes the whole question: across the trials, nobody in either group — stockings or no stockings — had a pulmonary embolism, a death, or even a symptomatic clot [s1]. The benefit is real and measured on silent clots found by screening; the dangerous outcomes travellers actually fear were too rare to appear at all.

What the trials measured

The Cochrane review pooled 11 randomised trials enrolling 2,906 passengers, all on flights lasting more than five hours [s1]. Nine of the trials compared wearing graduated compression stockings on both legs against not wearing them; the participants spanned low, medium, and high assessed risk of deep-vein thrombosis (DVT) [s1].

The headline result is large. Among 2,637 passengers with follow-up data in the both-legs trials, 50 developed a symptomless DVT — three of them wearing stockings, 47 not — giving an odds ratio of 0.10 (95% confidence interval 0.04 to 0.25), which the reviewers rated high-quality evidence [s1]. An odds ratio of 0.10 is roughly a ninety per cent reduction in the odds of a silent clot. In three of the trials, no symptomless clots occurred at all [s1]. Stockings also significantly reduced leg swelling (oedema), and produced a smaller, non-significant reduction in superficial vein thrombosis — an odds ratio of 0.45 (95% CI 0.18 to 1.13) [s1].

Why the caveat matters more than the headline

The word doing the heavy lifting is "symptomless." A DVT found only because researchers ultrasound every passenger's legs is not the same event as a clot that causes pain, swelling, or breaks loose and travels to the lungs. The review is explicit that no deaths, pulmonary emboli, or symptomatic DVTs were reported in any of the trials [s1]. So the stockings demonstrably move a surrogate outcome — clots detectable by screening — while the trials were far too small, and the serious events far too rare, to show whether stockings prevent the outcomes that would actually send someone to hospital.

That rarity is the second half of the story. A review of travel-associated venous thromboembolism summarising 18 studies concluded that air travel is a genuine risk factor for clots, but that the association is mild to moderate, with odds ratios between roughly 1.1 and 4 [s2]. It identified a dose-response relationship: risk rose by about 26% for every additional two hours of air travel, beginning after the first four hours (P=0.005) [s2]. The quality of that evidence was low, and the review noted that practice guidelines from different groups disagree with one another [s2].

What the guidelines converge on

Where the guidelines summarised in that review do agree is instructive. They generally hold that no prophylaxis is necessary for travellers without known thrombosis risk factors, and they favour conservative measures such as graduated compression stockings over drug-based prophylaxis for those who do have risk factors [s2]. Compression stockings are, in that framing, the low-risk intervention of choice precisely because their downside is negligible even if their benefit on serious clots is unproven — the opposite trade-off from blood-thinning drugs, which carry real bleeding risk [s2].

What this leaves a traveller

The defensible reading is narrow and useful. For a healthy person on a long flight, the absolute risk of a dangerous clot is low, and the trial evidence for stockings sits on symptomless clots rather than serious ones [s1] [s2]. For someone with existing risk factors — a prior clot, recent surgery, pregnancy, certain cancers, or clotting disorders — the risk is higher and the calculus different, and guidelines lean toward compression stockings over drugs for that group [s2]. Which category a given traveller falls into, and whether any additional measure is warranted, is a clinical judgement rather than a purchase decision, and this article does not make it for anyone.